Monoclonal Anti-KLK2 Antibody, Rabbit (M1D12)

この製品は開発中です。この製品に興味がある場合は、直接お問い合わせください。お客様のニーズに応じて、R&Dプロセスを加速することが可能です。
製品番号/仕様
価格
Availability
数量
HGS-M2817-20ul
$185.00
HGS-M2817-100ul
$485.00
HGS-M2817
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-KLK2 Antibody, Rabbit (M1D12) is a recombinant KLK2 primary antibody for IHC application.

Antibody Type

Recombinant Monoclonal

Clone

M1D12

Isotype

Rabbit IgG, Kappa

Host Species

Rabbit

Reactivity

Human

Specificity

React with KLK2 protein on the membrane and intracellular area of target cell/tissue.

Purification

Protein A purified.

Concentration

0.9~1.1 mg/ml

Form

Liquid

Formulation

Please contact us for detailed information.

Contact us for customized product form or formulation.

Shipping

Liquid product is shipped at blue ice.

Storage

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • 2°C to 8°C for 14 days;
  • -20°C to -70°C for 12 months.
Notices

Product Specific Notices: For research use only.

バックグランド

KLK2 encodes kallikrein-related peptidase 2, a highly active trypsin-like serine protease that selectively cleaves at arginine residues. It belongs to the kallikrein family and is primarily expressed in prostatic tissue, where it participates in proteolytic processing. KLK2 protein is found in the extracellular region, extracellular exosomes, and secretory granules. A central function of KLK2 is cleavage of pro-prostate-specific antigen into its enzymatically active form, placing it in zymogen activation and proteolysis. Its selective expression in the male reproductive system supports its role in reproductive tissue biology. Pathogenic relevance for KLK2 is reported in soft tissue sarcoma, and the gene is highly expressed in prostate tumor cells, where it has been described as a prognostic marker for prostate cancer risk.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now